HUMAN ALBUMIN SOLUTION FOR INFUSION 20% BEHRING [SIN14085P]

Product Info

HUMAN ALBUMIN SOLUTION FOR INFUSION 20% BEHRING

[SIN14085P]

4.1 Therapeutic indications
Restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate.
The choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on official recommendations.

4.2 Posology and method of administration
The concentration of the albumin preparation, dosage and the infusion-rate should be adjusted to the patient's individual requirements.

Posology
The dose required depends on the size of the patient, the severity of trauma or illness and on continuing fluid and protein losses. Measures of adequacy of circulating volume and not plasma albumin levels should be used to determine the dose required.
If human albumin is to be administered, haemodynamic performance should be monitored regularly; this may include:

• arterial blood pressure and pulse rate

• central venous pressure

• pulmonary artery wedge pressure

• urine output

• electrolyte

• haematocrit/haemoglobin

Method of administration
Human albumin can be administered by the intravenous route, either undiluted or after dilution in an isotonic solution (e.g. 5 % glucose or 0.9 % sodium chloride). See section 3 "Pharmaceutical Form" and 6.6 "Special precautions for disposal and other handling" – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information.
The infusion-rate should be adjusted according to the individual circumstances and the indication.
In plasma exchange the infusion-rate should be adjusted to the rate of removal.

4.3 Contraindications
Hypersensitivity to albumin preparations or to any of the excipients of the product.